Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
07 Mar 2023  |  Global  |  Technology Research
Global Gut Microbiome Growth Opportunities
Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape
This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untarg...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Feb 2023  |  Global  |  Technology Research
Trends and Technologies Poised to Change the Paradigm of Healthcare Delivery and Outcomes
Preventative and Precision Medicine, Digitalization, and Decentralization to drive Transformational Growth
The healthcare industry is undergoing a massive transformation, with a high focus on personalization and patient-centric care. It is embracing digital transformation and becoming more consumer-/patient friendly. The changing socioeconomic landscape, the high prevalence of chronic diseases, the massive COVID-19 pandemic, and the challenge of resourc...
$4,950.00
Special Price $4,207.50 save 15 %
-
19 Jan 2023  |  Global  |  Technology Research
Advances in Gene Editing Technologies in Healthcare
Next-generation genome editing tools and improved delivery are bolstering gene editing therapeutics and diagnostics.
Advancements in gene editing technology are boosting its adoption in various fields, including healthcare, diagnostics, agriculture, and industrial biotechnology. CRISPR, ZFNs, and TALENs are examples of technologies that have revolutionized the gene editing field. Moreover, with constant research efforts, new technologies such as base editing, pri...
$4,950.00
Special Price $4,207.50 save 15 %
-
21 Dec 2022  |  Global  |  Technology Research
Antibody-drug Conjugates: Technology Growth Opportunities
Disruptive Technologies and a Conducive Funding Environment are Fostering Growth
Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...
$4,950.00
Special Price $4,207.50 save 15 %
-
20 Dec 2022  |  Global  |  Technology Research
Advances and Growth Opportunities in RNA Vaccines
Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines
RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...
$4,950.00
Special Price $4,207.50 save 15 %
-
19 Dec 2022  |  Global  |  Technology Research
Assistive Reproductive Technologies: Innovations and Growth Opportunities
Non-invasive PGT and AI-based Decision Support Creating Transformational Growth in IVF Procedures
Assisted reproductive technology (ART) includes advanced fertility treatments and procedures, such as the manipulation of eggs, sperm, or embryos to increase the chances of a successful pregnancy. This study primarily examines the market for in vitro fertilization (IVF), a common ART procedure. It highlights innovations around the pre-implantation ...
$4,950.00
Special Price $4,207.50 save 15 %
-
19 Dec 2022  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Structural Heart Implants
Biomaterials and Design Advances Improve the Efficacy and Safety of Heart Valves and Occluders
Structural heart diseases (SHD) encompass cardiac conditions that cause abnormal blood flow inside the heart's chambers, which can be wrong blood flow direction or blood stagnation. Structural abnormalities in the heart lead to impaired functioning rather than the heart's blood vessels. The cardiovascular implants industry has developed prosthetic ...
$4,950.00
Special Price $4,207.50 save 15 %
-
15 Dec 2022  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Advanced Acute and Chronic Wound Care
Technology Strategy Through the Use of Sensor-based, Medicated, and Electroceutical Wound Dressings and Regenerative Wound Care to Revolutionize Acute and Chronic Wound Management
Human wounds, especially chronic nonhealing wounds, have emerged as a significant clinical challenge for healthcare providers due to traditional wound care products’ inability to treat biofilm-associated infections in wounds, prolonging the wound healing process and difficulty in reducing trauma during wound management. In addition, the rising nu...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Dec 2022  |  North America  |  Technology Research
Bionic Devices: Technology Innovations and Growth Opportunities
Disruptive Bionic Device Technologies Mimicking Natural Functioning of the Eyes, Kidneys, and Limbs
Bionic devices are mechatronic or electronic platforms that can perform the physical and biological functions of body parts or organs that are lost or damaged because of chronic conditions or accidents. Patients that suffer complete vision loss because of retinal diseases; upper and lower limb amputations caused by accidents or chronic diseases; an...
$4,950.00
Special Price $4,207.50 save 15 %
-
13 Dec 2022  |  Global  |  Technology Research
Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities
The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.
The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...
$4,950.00
Special Price $4,207.50 save 15 %